Education
About Us
Working with TipRanks
Follow Us
Aquestive Therapeutics (AQST)
NASDAQ:AQST
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 44.55M | $ 57.56M | $ 50.58M | $ 47.68M | $ 50.83M |
| Gross Profit | $ -15.58M | $ 39.69M | $ 29.75M | $ 28.29M | $ 35.84M |
| Operating Income | $ -71.05M | $ -30.77M | $ -15.10M | $ -42.07M | $ -34.68M |
| EBITDA | $ -71.05M | $ -26.62M | $ 1.18M | $ -39.58M | $ -45.11M |
| Net Income | $ -83.78M | $ -44.14M | $ -7.87M | $ -54.41M | $ -70.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 121.17M | $ 71.55M | $ 23.87M | $ 27.27M | $ 28.02M |
| Total Assets | $ 160.43M | $ 101.42M | $ 57.42M | $ 57.07M | $ 61.99M |
| Total Debt | $ 42.48M | $ 38.00M | $ 33.32M | $ 57.49M | $ 56.42M |
| Net Debt | $ -78.69M | $ -33.54M | $ 9.45M | $ 30.21M | $ 28.40M |
| Total Liabilities | $ 194.09M | $ 161.58M | $ 163.91M | $ 175.62M | $ 144.13M |
| Stockholders' Equity | $ -33.66M | $ -60.16M | $ -106.49M | $ -118.55M | $ -82.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -52.99M | $ -35.92M | $ -7.38M | $ -12.31M | $ -33.89M |
| Operating Cash Flow | $ -52.43M | $ -35.76M | $ -6.38M | $ -9.79M | $ -32.98M |
| Investing Cash Flow | $ -562.00K | $ -159.00K | $ -995.00K | $ -2.52M | $ -913.00K |
| Financing Cash Flow | $ 102.62M | $ 83.59M | $ 3.97M | $ 11.56M | $ 30.11M |